This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years (Pneumococci)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2009 by King Saud University.
Recruitment status was:  Not yet recruiting
Information provided by:
King Saud University Identifier:
First received: February 9, 2009
Last updated: February 11, 2009
Last verified: February 2009
The purpose of this study is to identify the S. pneumoniae serotypes strains and to determine antibiotic susceptibility.

Condition Intervention
Pneumococcal Disease Biological: pneumococcal conjugate vaccine(prevenar)

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Screening
Official Title: Serotyping of Pneumococci

Resource links provided by NLM:

Further study details as provided by King Saud University:

Primary Outcome Measures:
  • Incidence and serotypes of invasive pneumococcal dis. [ Time Frame: 6-8 months ]

Secondary Outcome Measures:
  • Antibiotic susceptibility [ Time Frame: 6-8 months ]

Estimated Enrollment: 400
Study Start Date: March 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Biological: pneumococcal conjugate vaccine(prevenar)
    to see the vaccine impact on pneumococcal diseases

Ages Eligible for Study:   up to 5 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • age less than 5 years

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00843895

Contact: Atef M. Shibl, PH D 00966505 30 2775

Sponsors and Collaborators
King Saud University
  More Information

Responsible Party: King saud university, wyeth Identifier: NCT00843895     History of Changes
Other Study ID Numbers: kingsadu
Study First Received: February 9, 2009
Last Updated: February 11, 2009

Keywords provided by King Saud University:
Laboratory based study
antibiotic susceptibilty
invasive strains

Additional relevant MeSH terms:
Pneumococcal Infections
Streptococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Heptavalent Pneumococcal Conjugate Vaccine
Immunologic Factors
Physiological Effects of Drugs processed this record on August 18, 2017